𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Randomized, Placebo-Controlled Trial Assessing the Effects of Rosiglitazone on Echocardiographic Function and Cardiac Status in Type 2 Diabetic Patients With New York Heart Association Functional Class I or II Heart Failure

✍ Scribed by Henry J. Dargie; Per R. Hildebrandt; Günter A.J. Riegger; John J.V. McMurray; Stephen O. McMorn; Jeremy N. Roberts; Andrew Zambanini; John P.H. Wilding


Book ID
119266455
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
409 KB
Volume
49
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.